Duluth, GA, United States of America

Philip Vincent Robledo

This inventor holds 1 USPTO granted patent. Top assignee: Medtronic Xomed, Inc.. Active years: 2007.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 60(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Philip Vincent Robledo

Introduction

Philip Vincent Robledo is a notable inventor based in Duluth, GA (US). He has made significant contributions to the field of ophthalmology through his innovative patent. His work focuses on improving ocular fluid drainage, which is crucial for various eye conditions.

Latest Patents

Robledo holds a patent for an "Article and method for ocular aqueous drainage." This ophthalmic implant is designed to be positioned in a recess created in the sclera. The implant features a body, feet for positioning in the anterior chamber, and a neck that connects the body and feet. The feet extend beyond the body and are curved to match the anterior chamber's curvature. The implant includes drainage passageways that facilitate the removal of ocular fluid from the anterior chamber. These passageways can be formed in the outer surfaces or through the interior of the implant, enhancing its functionality.

Career Highlights

Robledo is currently associated with Medtronic Xomed, Inc., where he continues to contribute to advancements in medical technology. His innovative approach to ocular implants showcases his dedication to improving patient outcomes in ophthalmic care.

Collaborations

Robledo has collaborated with notable colleagues, including James E Memmen and Scott M Hampton. Their combined expertise in the field has likely contributed to the success of their projects and innovations.

Conclusion

Philip Vincent Robledo's work in developing an ocular aqueous drainage implant exemplifies the impact of innovation in medical technology. His contributions are vital for enhancing treatment options in ophthalmology, and his ongoing work promises to further advance the field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…